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Metazoan development involves the successive acti-
vation and silencing of specific gene expression pro-
grams and is driven by tissue-specific transcription
factors programming the chromatin landscape. To
understand how this process executes an entire
developmental pathway, we generated global gene
expression, chromatin accessibility, histone modifi-
cation, and transcription factor binding data from pu-
rified embryonic stem cell-derived cells representing
six sequential stages of hematopoietic specification
and differentiation. Our data reveal the nature of reg-
ulatory elements driving differential gene expression
and inform how transcription factor binding impacts
on promoter activity.We present a dynamic core reg-
ulatory network model for hematopoietic specifica-
tion and demonstrate its utility for the design of
reprogramming experiments. Functional studies
motivated by our genome-wide data uncovered a
stage-specific role for TEAD/YAP factors in mamma-
lian hematopoietic specification. Our study presents
a powerful resource for studying hematopoiesis and
demonstrates how such data advance our under-
standing of mammalian development.
INTRODUCTION
Cellular identities in multicellular organisms are defined by their
individual gene expression programs and are established in a se-
ries of cell fate changes starting from pluripotent cells of the em-
bryo. The information on the balanced and coordinated up- and
downregulation of gene expression is encoded in our genome
and is read by transcription factors (TFs), which interact with
the epigenetic regulatory machinery to program the chromatin
of lineage-specific genes into active and inactive states. To un-572 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The Authderstand the mechanisms by which TFs establish and maintain
specific transcriptional programs, it is essential to investigate
developing biological systems, as illustrated by studies in non-
vertebrate models (Van Nostrand and Kim, 2011; Zinzen et al.,
2009).
Embryonic blood cells arise from early mesodermal cells via
hemangioblast and hemogenic endothelial intermediates (Med-
vinsky et al., 2011). Studies of chromatin programming and
gene expression during the generation of mature blood cells
from hematopoietic stem cells were instrumental in defining the
concept that development at the level of chromatin is a gradual
and hierarchical process starting long before the overt transcrip-
tional activation of lineage-specific genes (Bonifer et al., 2008;
Hoogenkamp et al., 2009; Org et al., 2015; Wamstad et al.,
2012; Wang et al., 2015). This notion is illustrated by the regula-
tory circuit essential for macrophage differentiation, the gene
encoding TF PU.1 (Spi1), and its target, the Csf1r growth factor
receptor gene (reviewed in Bonifer et al., 2008). Both are targets
of RUNX1, but Spi1 expression is induced prior to Csf1r. Early
Spi1 induction follows an initial enhancer priming event by TFs
upstream of RUNX1 followed by upregulation via autoregulation
(Leddin et al., 2011; Lichtinger et al., 2012), whereas subsequent
full expression of Csf1r requires the concerted action of RUNX1,
PU.1, and PU.1-induced factors (Krysinska et al., 2007; Lich-
tinger et al., 2012). This example illustrates the complexity of
the molecular mechanisms underlying the establishment of
cell-type-specific expression profiles. However, the global tran-
scriptional control mechanisms underlying such dynamic pro-
gression events have remained largely obscure, because of a
lack of comprehensive information on TF binding and the dy-
namic nature of the chromatin template with which they interact.
We also know very little about how such transcriptional control
mechanisms are interlinked with outside signaling.
The developmental hierarchies of early embryonic hematopoie-
sis are recapitulated indifferentiatingembryonic stemcells (ESCs)
(Lancrin et al., 2010), which provide a tractable system capable of
generating the cell numbers required for performing multiple
genome-wide assays on the same samples. Recent studies
have investigated the function of individual regulators at specificors
developmental stages, such as early mesodermal patterning
functions of the TF SCL/TAL1 and the RUNX1-controlled transi-
tion from hemogenic endothelium to hematopoietic progenitors
(HPs) (Lancrin et al., 2012; Lichtinger et al., 2012; Lie-A-Ling
et al., 2014; Liu et al., 2015; Tanaka et al., 2012). However, while
a number of studies have examined individual cell fate transitions
or investigated the differentiation of mature blood cells from he-
matopoietic stem cells (Garber et al., 2012; Lara-Astiaso et al.,
2014; Tsankov et al., 2015), no study to date has reported an inte-
grated genome-scale analysis of an entire developmental time
course from early ESCs to fully defined blood cells.
In this study, we surveyed the global transcriptional journey
from the ESC to the terminally differentiated state of macro-
phages via blood precursor cells by generating data for RNA
sequencing (RNA-seq), DNase sequencing (DNA-seq), and
chromatin immunoprecipitation sequencing (ChIP-seq) for his-
tone marks and 16 different TFs across six sequential develop-
mental stages. To facilitate access across the wider scientific
community, we have integrated all genome-scale datasets into
an online resource with advanced browse, search, and analysis
capabilities. We have exploited our datasets to assemble a core
regulatory network model that was able to inform the design of
TF-mediated reprogramming strategies for the production of
blood cells from fibroblasts. Furthermore, computational anal-
ysis of regulatory elements revealed the nature of TFs involved
in stage-specific priming of distal elements, and informed func-
tional validation experiments identifying TEAD/YAP interaction
as a stage-specific regulator of early murine blood specification
in vitro and in vivo. Finally, we identified TEAD target genes and
their associated pathways, thus significantly enhancing our un-
derstanding of the signaling processes driving embryonic blood
cell development.
RESULTS
Capturing a Complete Developmental Pathway using
Genome-Scale Technologies
To study the specification of hematopoietic cells and their further
differentiation, we employedmouse ESC in vitro differentiation to
purify well-defined intermediate cell populations en route from
pluripotent ESCs to adherent macrophages (Lancrin et al.,
2009;Sroczynskaet al., 2009),makinguseof aBrachyuryGFP re-
porter (Fehling et al., 2003) and surface marker expression. Full
details of this strategy are given in Figure S1A. In brief, pluripotent
ESCs differentiate to mesoderm (MES) cells (Bry:GFP+/Flk1),
which then progress to the hemangioblast (HB) stage (Bry:GFP+/
Flk1+) with smooth muscle, endothelial, and hematopoietic po-
tential, followed by the hemogenic endothelium (HE) stage that
has both endothelial and hematopoietic potential (CD41/Tie2+/
Kit+). HE cells then undergo the endothelial-hematopoietic transi-
tion (EHT) involving a shape change, after which they are fully
committed to blood (CD41+ cells). CD41+ cellswere further differ-
entiated to generate CD11b+macrophages (MAC). From purified
cells we determined global gene expression profiles by RNA-seq
andmapped the full set of cis-regulatory elements at each devel-
opmental stage by global DNaseI hypersensitive site (DHS) map-
ping (DNaseI-seq).WeusedChIP-seq to generate globalmapsof
TF binding for key regulators across this entire developmental
pathway as well as global patterns of H3K4me3, H3K9ac,DevelH3K27ac, and H3K27me3 histone modifications to investigate
how TFs programmed the chromatin landscape. TFs were cho-
sen according to the cell type in which they were expressed (Fig-
ure S1B), and all integrative analysis of ChIP and DHS data was
focused on genomic regions found in at least two independent
biological experiments (Table S1). Our datasets were comple-
mented with published data for undifferentiated mouse ESCs
(Chen et al., 2008; Whyte et al., 2013). The quality of this data
resource is exemplified in a browser window depiction of
sequence tags aligning to the Tal1 locus (Figure 1A), which en-
codes a key regulator of early blood specification (Shivdasani
et al., 1995; Wilson et al., 2009).
Initially, we used RNA-seq to investigate the dynamic changes
of gene expression across the six differentiation stages and how
these changes were reflected in the simultaneous changes in
chromatin structure. To this end, we clustered RNA-seq (Fig-
ure 1B; Tables S2A and S2B) and DNaseI-seq data (Figure 1C).
For both features, samples clustered in line with the known
developmental progression, with an early cluster consisting of
the ESC, and the more closely related MES and HB and a later
cluster made up of HE and HP with the macrophage samples
clustering separately. We then performed a similar analysis using
TF binding data (Figure 1D). While cell-type-specific clustering of
specific TF binding events were evident in ESCs and for certain
TFs (e.g. FLI1) in HPs and MACs, others (such as C/EBPb)
showed patterns predominantly driven by the identity of the fac-
tor rather than the tissue type (Figure 1D).
To facilitate inspection of individual genes and generate a
resource for further data analysis, we developed a web interface
to allow streamlined access for the wider scientific community:
http://www.haemopoiesis.leeds.ac.uk/data_analysis/. The web
portal provides access to both raw and processed data as well
as user-driven analysis options. These include queries for spe-
cific genes and gene sets across our multi-omics datasets, as
well as the visualization of all our data through a custom installa-
tion of the UCSC genome browser. In the following sections, we
describe how our data can be explored to inform the functional
validation of potential mechanisms.
Identification of the Complete Set of Differentially
Active cis-Regulatory Elements Driving Hematopoietic
Specification
We next inspected the nature of genes changing expression at
each cellular transition. 9,627 transcripts from 8,986 genes
were dynamically expressed during the developmental time
course (Figures S1C–S1E; Tables S2A and S2B). Expression
changes between any two sequential developmental stages
(transitions T1 to T5, Figure 1E) showed specific enrichment for
functionality with the ensuing stage of development for upregu-
lated genes (e.g. T4 shows enrichment for hematopoiesis), and
alternative cell fates for downregulated genes (e.g. T4 angiogen-
esis, heart/muscle development; Table S2C).
To capture dynamic expression patterns across the entire
developmental pathway and correlate such changes with alter-
ations in chromatin structure and TF binding, we performed
unsupervised/k-means clustering, which identified 31 major
expression clusters E1 to E31 (Figure 1F and Table S3A) repre-
senting different gene ontology (GO) categories (Table S3B and
Figure S4A). For example, E17–E19 represent clusters withopmental Cell 36, 572–587, March 7, 2016 ª2016 The Authors 573
Figure 1. Integrated Global Data over a Whole Developmental Pathway
(A) UCSC browser screenshot depicting the Tal1 locus aligning RNA-seq, DNaseI-seq, and ChIP-seq data from the six stages of development depicted in the
left-hand flow chart. The stage-specific color scheme is used in all subsequent figures. Panels display ChIP-seq data for four histone modifications (left) and
16 different TFs (right) plus DHS data. The grayed-out regions indicate known regulatory regions: from left to right, promoters 1a and 1b, enhancers +19 and +40.
(B–D) Hierarchical clustering of cell populations based on the normalized expression values of the genes (B), normalized correlation among the DHS sites (C), and
correlation among the TF sites (D). The correlations were normalized between 1 and +1 to preserve the color scale. ESC, embryonic stem cell; HB,
hemangioblast; HE, hemogenic endothelium; HP, hematopoietic progenitors, MES, mesoderm.
(E) Functional enrichment for genes that are differentially regulated during developmental transitions (T1–T5) in the progression of hematopoietic commitment.
(F) The expression dynamics of the differentially expressed genes in the pathway given in (A) that are clustered into 31 patterns. The standardized expression
values (zij) of the differentially regulated genes in the developmental pathway (Figure S1E) were clustered into 31 expression patterns, and the plot shows the
expression profiles of these patterns. The methodology is detailed in Supplemental Experimental Procedures.increased expression in macrophages, and all are enriched for
functions relating to the immune response. Similarly, pattern
E11with upregulation inHEanddownregulation inHP is enriched
for functions relating to vasculogenesis and adhesion, whereas
pattern E20with upregulation towardHP is enriched for functions
relating to hematopoiesis (Figure S4Ai–S4Aiv). Thus, our expres-
sion dataset defines distinct gene sets relevant for specific
developmental transitions during early blood specification.574 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The AuthWe next investigated the correlation between expression ki-
netics and dynamic changes of chromatin at the gene promoters
(Figures 2A and S2A) by using ChromHMM, which was reported
as an automated computational system for annotating chromatin
states (Ernst and Kellis, 2012). We modified this methodology to
integrate both histone modifications and DNaseI accessibility
data. The latter indicates regions of chromatin bound by TFs
(Cockerill, 2011) and allows for the distinction between inactiveors
(legend on next page)
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chromatin regions (absence of DHS) and repressed/poised
regions carrying H3K27me3. An initial number of 23 chromatin
states (see Figure S2B) was further compressed, providing a
simple four-state model of active (DHS marked with H3K4me3
and acetylated H3), repressed (marked with H3K27me3), poised
(DHS marked with H3K27me3 but also acetylated H3 and/or
marked with H3K4me3), or unmarked chromatin (Figure 2A). Ex-
amples (Nanog, Runx1) for dynamic alterations in promoter state
are shown in Figure S2C, demonstrating that such changes
occur gradually, both during the transition from the active to
the inactive state and during gene activation. This behavior is
also evident on a global scale with all differentially expressed
genes (Figure S2D). It was proposed that poised promoters of
key regulatory genes are held in this state until developmental
cues shift the balance from poised to active or repressed states
(as in the case of Runx1). The promoters of some genes highly
expressed in macrophages indeed transit through a poised
state, which in many cases is already evident in ESCs (Fig-
ure S2D). However, transitions from the unmarked or repressed
state are more frequent (Figure S2D, last row at the bottom).
A direct correlation between promoter state and gene expres-
sion is not seenwith all differentially expressed genes (Figure 2B).
Promoters of around one-third of differentially regulated genes
are persistently in the active state despite highly dynamic
gene expression (Figure 2B, highlighted). When this gene set
was investigated for GO term enrichment, we found that most
of their functions were ‘‘housekeeping’’ roles pertinent to regula-
tion of cell cycle, protein catabolism, transport, and localization
(Figures 2B and S2D; Table S4).
To link gene expression with the chromatin state of distal cis-
regulatory elements, we associated them with their nearest
genes and correlated changes in their chromatin state with the
31 gene expression patterns across the differentiation pathway
(Figures S3A and S3B depict the actual expression patterns
as heatmaps). This comparison demonstrates a strong correla-
tion between the dynamics of the chromatin state of distal
elements and gene expression, indicating that most of these
elements function as enhancers. We noted that the number of
distal elements that displayed a poised or repressed chromatin
state was small. These results add to the increasing evidence
that cell-type-specific spatiotemporal expression patterns are
largely driven by distal regulatory elements (Lara-Astiaso et al.,
2014) and in addition demonstrate that such elements are in
either the active or inactive chromatin state.
Chromatin Dynamics and TF Binding Determines the
Differential Activity of cis-Regulatory Elements
We next addressed the question of which TFs were responsible
for the cell-stage-specific opening of chromatin. We therefore
determined dynamic DHS patterns during the differentiationFigure 2. Chromatin Programming during Progressive Lineage Comm
(A) Schematic diagram of the method used to coarse grain the 23-state chromat
(B) Clustering of promoters (1Kb up or downstream of the transcription start site
expression pattern of genes that are constitutively expressed (right).
(C and D) Integration of DHS pattern and TF binding. (C) Methodology of the inte
events and the p values denoting the significance of overlap are depicted as gray
(columns) patterns across the six stages with the population size of each DHS
patterns with a population size >100 were considered.
576 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The Authtime course and classified DHS patterns using a binary code
with six digits (Figures 2C and 2D). We then performed pairwise
comparisons between all our DHS patterns with each of the
32 TF ChIP-seq experiments (our own and publicly available
data). Linking a set of regulatory genomic regions to annotated
gene sets is sensitive to the varying sizes of the intergenic re-
gions. We therefore used gene-set control analysis (GSCA)
(Joshi et al., 2013), a tool designed to account for the differing
sizes of such regions, to calculate pairwise correlation between
TF ChIP-seq peak sets and expression gene sets, thus identi-
fying all significant overlaps between TF binding events and
DHS appearance. Figure 2D shows the most prevalent patterns
of open chromatin over the six stages of development overlaid
with the most significant TF binding events which in general,
but not always, correlate with DHS presence. The most frequent
DHS patterns are stage specific, over half of which involved DHS
present only in macrophages (000001, 15,443 DHSs) and a
quarter in ESC (100000, 7,302 DHSs). Notably, DHSs exclusively
open in the HE (000100, 4,732 DHSs) are already primed by TF
binding in HBs. The remaining patterns represent approximately
30% of all DHS whereby the majority of all patterns are contin-
uous over at least two developmental stages. A common DHS
pattern is 111111 (6,750 occurrences), the majority of which
are CpG island promoters (Figure S4B) with a constitutively
active chromatin state (Figure S4C). This class of DHS also con-
tains the majority of binding events for C/EBPb prior to the HP/
MAC stages, suggesting a more widespread role of this tran-
scription factor in development than previously thought.
Early binding of both LMO2 and TAL1 is highly significant in
regulatory elements whose chromatin is first opened in HBs,
HEs, or HPs, and include binding prior to the appearance of overt
DHS sites, which is indicative of TF-mediated enhancer priming
(see pattern DHS_000110). PU.1 binding shows significant over-
lap with DHS patterns in HPs but is also found at sites that only
become hypersensitive in MACs. This suggests that PU.1 can
prime MAC-specific regulatory regions already in early multi-
potent progenitors, lending weight to the finding that it is capable
of opening chromatin (Garber et al., 2012; Natoli et al., 2011; Bar-
ozzi et al., 2014; Heinz et al., 2010, 2015).
We next correlated the statistical significance of the dynamics
of distal DHS patterns with dynamic gene expression patterns
(Figure S3B). This again demonstrates that the dynamics of
chromatin accessibility at distal sites correlates well with the
dynamics of gene expression (Figure S3B).
The Complex Interplay between Chromatin Dynamics,
Gene Expression, and TF Binding Events
Our next analysis determined the combinatorial pattern of TF-
DNA interactions driving target gene expression at key stages
of blood development. We therefore interrogated the 31itment
in model to four potential chromatin states.
, TSS) based on their chromatin state patterns (left) and the clustering of the
grative analysis of chromatin dynamics and TF binding events. (D) TF binding
-scale density plots, shown as dots. Integration of DHS (rows) and TF binding
pattern given on the right-hand side. For significance calculations only DHS
ors
Figure 3. Integration of Chromatin Dynamics, TF Binding Events, and Gene Expression during Hematopoietic Specification
(Left) Flow diagram of data integration. The average expression values (log10(FPKM)) of genes in expression patterns E1 to E31 were calculated for each
developmental stage. The significance (p < 0.0001) of the overlap between the genes in each expression pattern and a given TF ChIP-seq peak set was obtained
using gene-set control analysis. Z scores were obtained from the mean enrichment of H3K27ac in TF binding sites at these loci using bootstrapping. (Right)
Average expression levels for each pattern (rows) are shown as a red-blue heatmap (see key), with columns for each cell type labeled at the top. The columns are
further divided into TF ChIP-seq experiments, and the significant overlap between TF binding events and gene sets belonging to each expression pattern are
depicted by gray-scale density plots shown as dots (see key). Significant overlap of these binding events and H3K27ac sites are also shown as a density plot
depicted by yellow-green boxes (see key).expression clusters (Figure 1F) to ascertain (1) whether expres-
sion patterns correlated with enriched binding of any of our
examined 32 TF datasets to these genes, and (2) how such bind-
ing events correlated with histone H3K27 acetylation at this
position. For visual inspection, the TF binding and histone acet-
ylation data were then overlaid onto a heatmap summarizing
gene expression for patterns E1–E31 (Figure 3). This analysis
shows the overall correlation between dynamic transcription fac-
tor binding, histone acetylation, and gene expression. The genes
expressed in patterns E17–E20 are associated with increased
gene expression during hematopoiesis, all showing early low-
level induction prior to high-level expression (Table S3). This in-
duction is associated with significant binding of hematopoietic
regulators, but not MEIS1. Highly significant early binding of
LMO2/TAL1 in HB and FLI1/LMO2/TAL1 in HE occurs in genes
expressed in patterns E9–E11. All three patterns are associated
with binding of the repressor GFI1 in HP and with the repression
of gene expression inmacrophages. Patterns E9 and E11 involve
upregulation of genes in the major HB-HE transition but then
downregulation in HPs. Both sets of genes are enriched for func-Develtions relating to vasculogenesis, heart development, and cell
adhesion (Figure S4A). Our results therefore highlight GFI1 as a
candidate regulator involved in downregulating genes involved
in non-hematopoietic cell fates following the HE to HP transition.
This is consistent with data in the mouse that demonstrate a fail-
ure of EHT in the combined absence of GFI1 andGFIB in addition
to the continued expression of endothelial genes (Lancrin et al.,
2012; Lie-A-Ling et al., 2014; Thambyrajah et al., 2016). In sum-
mary, our analysis provides a highly informative integrated view
of the dynamic relationships between gene expression, chro-
matin state, and TF binding.
ADynamic CoreGeneRegulatory Network Driving Blood
Development
To uncover the hierarchy of transcription factors driving blood
specification forward, we generated gene regulatory network
(GRN) representations connecting all 16 TFs analyzed by ChIP-
seq, with separate representations for all six stages of develop-
ment. To visualize different features, we illustrated multiple
different data types within a single GRN representation at eachopmental Cell 36, 572–587, March 7, 2016 ª2016 The Authors 577
locus (Figure 4). Annotation for each of the six sequential devel-
opmental stages provided effective representation of the dy-
namics of cellular states, highlighted the chromatin features of
the promoter of each gene locus, and indicated how interactions
between a core set of key regulators drives developmental pro-
gression and terminal differentiation.
In ESCs all four pluripotency TFs participate in a highly con-
nected core network circuit and already at this stage bind loci
for hematopoietic TFs, including Cebpb, Elk4, Gata2, Lmo2,
Meis1, Runx1, and Tal1, which display open or poised chromatin
at their promoters, but also bind Gfi1b, Gata1, and Spi1, whose
promoters are organized in closed-unmarked/repressed chro-
matin. As early as the HB stage, several hematopoietic regulator
genes are upregulated, including Tal1 and Lmo2, which exhibit
autoregulation and co-regulate multiple genes. These include
Fli1 and Meis1, both of which are upregulated upon differentia-
tion into HE. This stage is characterized by the involvement of
LMO2, TAL1, and FLI1 (and in some cases MEIS1) in co-regu-
lating genes for multiple hematopoietic TFs, revealing a densely
connected GRN composed of potential feedback loops, which
is likely to set the stage for the next step of hematopoietic
commitment.
The HP stage shows highest expression for many of the key
hematopoietic TFs, with binding events being complex and
combinatorial. All ten TFs tested at this stage bind to Gfi1,
Gfi1b, and Runx1, and nine out of ten bind to Cebpb and Tal1
(the exceptions being RUNX1 and GFI1B, respectively). LMO2,
TAL1, and to some extent FLI1 continue to co-bind and at this
stage all target genes are shared with GFI1, consistent with the
results shown in Figure 1D. FLI1 no longer binds to Lmo2 or
Meis1, both of which are strongly upregulated. While Gata1 is
upregulated by a combination of GFI1/LMO2/TAL1, Gata2 is
bound by C/EBPb, TAL1, LMO2, FLI1, GATA1, GFI1, and
GFI1B and is downregulated, uncovering a potential feedback
mechanism regulating this TF within the network.
In macrophages, part of the HP-specific network is decon-
structed with the further downregulation of early hematopoietic
regulator genes such as Gata2 and Tal1 and a strong increase
in the expression of PU.1 and C/EBPb, which dominate global
binding patterns. Within the GRN both TFs already share many
target genes in HPs, including all genes encoding for experi-
mental TFs (14 loci in total). Nine of these loci (Cebpb, Elk4,
Fli1, Gata2, Lmo2, Meis1, Runx1, Spi1, Tal1) are also bound by
FLI1 at this stage where Lmo2 and Tal1 are downregulated.
Taken together, our datasets provide deep insights into the reg-
ulatory processes that control the dynamic rewiring of network
connections during blood cell specification and differentiation.
In the remaining part of this article we provide examples of
how these data can be used to gain insights into the regulation
of hematopoietic specification.
Hierarchy Matters: TAL1/LMO2, but Not FLI1/GATA2,
Can Reprogram Fibroblasts into Hematopoietic Cells
A number of recent publications reported a variety of TF combi-
nations capable of generating blood cells via the reprogramming
route (Batta et al., 2014; Elcheva et al., 2014; Pereira et al., 2013;
Riddell et al., 2014; Sandler et al., 2014). We reasoned that the
most likely factors capable of activating such a program would
be those that (1) are expressed first during blood specification578 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The Authand (2) bind to a large number of genes required for blood cell
development. Four tested factors fulfill these criteria, GATA2,
TAL1, LMO2, and FLI1, with all of their respective genes being
activated at the hemangioblast stage (Figure S1B). Figure S5A
shows an extended transcriptional network highlighting TFs
that have been used for reprogramming experiments demon-
strating that most binding events within the hematopoietic tran-
scriptional network involve TAL1/LMO2 which interact with one
another, autoregulate, and bind Fli1 and Gata2. Moreover, these
factors synergize in driving hematopoietic development in zebra-
fish (Patterson et al., 2007). We therefore tested the hypothesis
that TAL1/LMO2 overexpression would be sufficient to activate
the hematopoietic developmental program in mouse embryonic
fibroblasts (MEFs). To this end we transduced wild-type MEFs
or MEFs carrying a doxycycline-inducible allele of Tal1 with
different combinations of expression vectors for the four factors
(Figure 5A) and ensured that each construct was efficiently over-
expressed (Figure S5B). We then scored the number of hemato-
poietic colonies (Figure 5B) and measured the activation of a
blood-cell-specific gene expression program using RNA-seq
(Figure 5C). These experiments show that (1) reprogramming
generates cells with a gene expression profile that is highly
correlated with that of HPs, (2) TAL1 and LMO2 are sufficient
for reprogramming, (3) both are also necessary even in the pres-
ence of GATA2 and FLI1, and (4) GATA2 and FLI1 alone cannot
reprogram efficiently even in the presence of either TAL1 or
LMO2. Figure 5D shows that at least 13 important hematopoietic
regulator genes are bound by the LMO2/TAL1 complex during
the HB-HE transition, far exceeding those by any of the other
tested factors. In addition, in HP, TAL1 and LMO2 cooperate
to upregulate a battery of genes encoding downstream factors
whose expression is upregulated, such as Runx1, Gata1, and
Spi1 (Pu.1). These experiments demonstrate that the integrated
analysis of time course TF binding, chromatin accessibility/
modification, and expression data enables to highlight those
factors that are on top of the hierarchy of tissue specification
and are involved in the activation of themajority of genes govern-
ing lineage-specific gene expression programs. We believe that
this principle will be applicable in multiple developmental
settings.
Identification of Factors Driving Key Stages of Blood
Specification: A Role for TEAD/YAP
We next used our dataset to identify transcriptional regulators of
blood cell specification. We reasoned that cell-stage-specific
regulators would leave their mark in the epigenome by occu-
pying their respective binding motifs within cell-stage-specific
DHS. To capture all relevant regulatory regions at the genome-
wide scale, we used our chromatin accessibility data to perform
a pairwise comparison of distal DHS from one cell type with all
others as outlined in Figure 6A. For each set of DHSs unique to
a given cell population, we determined relative enrichment for
sequence motifs and performed a clustering analysis against
cognate motifs of TFs expressed in these cells. Our analyses
recovered the known role of specific factors in the relevant cell
types. In ESCs the pluripotency factormotifs form a distinct clus-
ter, whereas the RUNXmotif is predominantly enriched at the HP
stage (Figure 6B, blue arrow), where this TF is critically required
(Chen et al., 2009; Lancrin et al., 2009). These results wereors
(legend on next page)
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confirmed by analyzing enriched motifs within the TF ChIP-seq
peaks (Figure S6A). Besides confirming the presence of the mo-
tifs for the assayed factors, we also discovered a significant cell-
stage-specific enrichment of co-localizing motifs. An example is
the significant enrichment of GATA motifs near the TAL1/LMO2
complex over several developmental stages, confirming the
important role of this factor in forming a complex regulating he-
matopoietic genes (Wadman et al., 1997;Wilson et al., 2010).We
also observed a strong enrichment of TCF7L1/2 motifs in TAL1/
LMO2 peaks at the HB state, which are also predominant in the
cell-specific DHS at this stage. TCF/LEF are mediators of Wnt
signaling and have been shown to regulate hematopoietic spec-
ification (Sturgeon et al., 2014), raising the possibility that at this
developmental stage elements binding the TAL1/LMO2 complex
are WNT-signaling responsive.
The same analysis also uncovered enriched motifs for factors
not yet linked with mammalian hematopoietic development,
such as a significant enrichment for TEAD binding motifs early in
hematopoietic development, specifically at the HB stage (Fig-
ure 6B, red arrow). TEAD motifs significantly co-localized with
peaks for LMO2 and TAL1 in HBs and with TAL1/LMO2/FLI1 in
the HE, but not in HPs (Figure 6C). TEAD transcriptional activity
is controlled by the Hippo signaling network, which has emerged
as a highly conserved pathway controlling cell proliferation, cell
shape, organ size, and cell fate decisions in several differentiation
pathways, including hematopoiesis in Drosophila (Dong et al.,
2007; Ferguson and Martinez-Agosto, 2014; Milton et al., 2014).
In mammals, when the Hippo pathway is activated, the MST
and LATS kinases phosphorylate the transcriptional co-regulator
YAP, which is then sequestered in the cytoplasm and conse-
quently cannot form a complex with its nuclear DNA binding part-
ner TEAD. When Hippo signaling is inactive, YAP interacts with
TEAD factors in the nucleus to positively or negatively regulate
Hippo signaling-responsive target genes (Yu and Guan, 2013).
To test whether TEAD factors are involved in regulating
mammalian hematopoietic specification, we first looked for the
presence of TEAD and YAP and any change in nuclear localiza-
tion of YAP in mouse embryos. Figure 7A shows cross sections
of developing blood islands from the yolk sac of embryonic day
7.5 (E7.5) mouse embryos stained with antibodies against TIE2
to identify endothelial cells, TEAD (upper panel) and YAP (lower
panel). The images demonstrate a nuclear localization of YAP
prior to the EHT but a cytoplasmic localization in hematopoietic
cells. Staining of hematopoietic clusters emerging from the dor-
sal aorta from E10.5 mouse embryos (Figures S7A and S7B) also
shows the absence of nuclear YAP in committed hematopoietic
cells. The same is true for in vitro differentiated cells, where YAP
is predominantly localized in the nucleus at the HB stage (Figures
S6B and S6C) and then is localized in the cytoplasm in CD41+ HP
cells (Figure S6D), indicating a precise temporal regulation of
TEAD activity during hematopoietic specification.Figure 4. Dynamic Gene Regulatory Network Driving Hematopoietic S
For each developmental stage the 16 TFs used in ChIP-seq experiments are show
expression (see key). The chromatin accessibility at each promoter is shown as op
color of the node corresponds to the promoter state according to the coarse-gr
events of a TF (source) at loci encoding all TFs (target). The arrow color relates to
node indicates absence of ChIP data. For information about which ChIP experim
include C/EBPb binding in the ES cell GRN, since the publicly available datasets
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important for hematopoietic differentiation, we performed both
in vitro and ex vivo experiments using verteporfin, which specif-
ically inhibits TEAD-YAP complex formation, thus mimicking the
Hippo pathway activation (Liu-Chittenden et al., 2012). Culturing
ESC-derived embryoid bodies with the inhibitor blocked the
emergence of CD41+ HPs, but only when administered at early
time points prior to day 5 of embryoid body (EB) culture when
the emergence of blood cells occurs (Figures 7B and 7C). Dur-
ing normal HB development from mesodermal cells, the expres-
sion of Fgf5 and Bry are downregulated concomitant with the
upregulation of Flk1 expression (Fehling et al., 2003). This pro-
cess was abolished after treatment of isolated Bry+ ME cells
with verteporfin (Figure S6E). We also explanted FLK1+/
CD41 cells from E7.5 embryos and differentiated them into
CD41+ hematopoietic precursor cells on stromal cultures in
the presence or absence of verteporfin (Figure S6F), and
compared their response to cultured committed CD45+ he-
matopoietic cells from E10.5 embryos (Figure S6G). Again, the
addition of the inhibitor inhibited blood cell emergence and
survival prior to, but not after hematopoietic specification.
Moreover, genes encoding YAP and all TEAD factors were
downregulated from the HP stage onward with expression
essentially absent in macrophages (Table S2A). Together, these
data suggest that (1) TEAD/YAP interaction is required at early
stages of hematopoietic commitment and (2) YAP localizes
outside of the nucleus after the EHT, suggesting that Hippo
signaling is switched on in these cells.
Identification of TEAD Target Genes
Having established an important role of TEAD and YAP
interaction in hematopoietic specification, we performed
ChIP-seq for TEAD4 from in vitro differentiated Flk1+ heman-
gioblast cells to map its target genes. We mapped 5,234
TEAD4 binding regions (with manual validations shown in Fig-
ure S7C), including the Tal1 locus (Figure 7D). Two-thirds of
the binding sites occur in distal regions. Approximately 30%
of all TEAD peaks (1,563) are in DHS that are active throughout
all stages of differentiation (DHS pattern 111111, Figure 3, left
panel, and Figures S4B and S4C). Most of these sites (1,342)
are promoters, indicating that TEAD may fine-tune the expres-
sion of CG island promoters that predominate in such sites.
TEAD binding sites in distal peaks are found predominantly
in stage-specific DHS. A significant number of TEAD4 binding
sites overlap with LMO2 and TAL1 binding sites in HB (Fig-
ure S7D), which is in concordance with the enrichment for
TEAD motifs in early LMO2 and TAL1 binding events (Figures
6B and 6C).
Analysis of pathways enriched in TEAD4 bound genes (Table
S8) revealed focal adhesion and Rap1 signaling as well as Wnt
and transforming growth factor b signaling to be the top-scoringpecification
n as nodes in a GRN. The color of each node corresponds to the level of gene
en/circular (DHS presence) or closed/octagonal (DHS absence), and the border
ain four-state model mentioned in Figure 2 (see key). Arrows indicate binding
the promoter state of the target TF encoding gene. No emanating arrow from a
ents were conducted in which cell type, see Figure S1B. Note that we did not
did not contain the respective data.
ors
Figure 5. Gene Regulatory Network Analysis Is Informative for Reprogramming Success
(A) Schematic of reprogramming experiments.
(B) Bar chart showing the number of hematopoietic colonies generated from fibroblast cells after overexpression of different combinations of TAL1, LMO2, FLI1
and GATA2 as indicated in the table below. Grayed areas in this table highlight successful production of hematopoietic colonies. The number of hematopoietic
colonies generated from fibroblast cells after overexpression of Tal1, Lmo2, Fli1, Gata2, and the indicated combinations of these four TF encoding genes. Data
presented are mean ± SEM of individual experiments (n = 7).
(C) Correlation coefficient analyses of gene expression profiles generated by RNA-seq from hematopoietic cells generated by reprogramming from MEFs at day
12 and day 21 (D12 and D21) of the experiment with gene expression patterns generated from in vitro differentiated cells. The heatmap shows the correlation
between expression data from each stage (columns) and each experiment (rows). All red/pink rectangles show correlation values that are significantly different
from all blue rectangles (Z transform test, p < 0.01).
(D) Model depicting the hierarchy of transcriptional regulation during hematopoietic differentiation. Target TF genes are listed in the arrow, with those that are
upregulated after binding events listed on the left and those that are downregulated listed on the right.
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Figure 6. Chromatin and Transcription Factor Binding Dynamics and Identification of Regulators
(A) Schematic representation of the methodology for pairwise motif clustering at distal DHS (for used motifs see Table S6).
(B) Relative motif enrichment (RE) scores for the motifs in DHS unique to a given cell type compared with each of the other five cell types were clustered. RUNX
and TEADmotifs are indicated by blue and red arrows, respectively. The significance of the RE scores were computed using the bootstrappingmethod (Table S7).
(C) Significance of co-localization of TEAD motifs in TF ChIP peaks. Red stars indicate significant co-localization.pathways, all of which are known to influence hematopoietic and
endothelial specification. In addition, a number of genes impor-
tant for hematopoiesis are bound by TEAD, including the gene
for the hematopoietic master regulator RUNX1 as well as Kit,
which encodes a growth factor receptor crucial for the growth
of hematopoietic precursor cells. In summary, our data indicate
that TEAD factors target genes that regulate hematopoietic
specification during the critical period leading to the EHT.
DISCUSSION
A Gene Regulatory Network Model for Hematopoietic
Specification in the Embryo
The comprehensive experimental and computational studies of
embryonic blood cell development reported here elucidate in582 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The Authfine detail how the interplay between cell-stage-specific TFs
and the chromatin landscape drives differential gene expression
during ontogeny. As indicated by the presence of a DHS, thema-
jority of active cell-type-specific distal cis-regulatory elements
correlate with significant binding of the measured TFs. Our
data show a high complexity of developmental stage-specific
TF assembly, with some factors binding first to be joined by
others later in development, and with chromatin modifications
following suit. Concurrent with the long-standing concept of
developmental priming of distal cis-regulatory elements, a num-
ber of genes are bound by TFs in progenitor stages prior to high-
level expression later in development. Recent experiments
have shown that the early binding of TFs to distal elements of
lineage-specific genes is required for the correct timing of
gene activation and the repression of alternative fates (Lichtingerors
Figure 7. A Role for TEAD Factors in Early Hematopoietic Specification
(A) TEAD and YAP localize to the nucleus of a subset of TIE2+ endothelium within yolk sac blood island of E7.5 embryos. E7.5 embryo sections were stained as
indicated. Asterisks mark TIE2+ cells on the outer edge of the developing blood island, which show nuclear localization for both TEAD and YAP. Cells within the
blood island are maturing primitive erythrocytes and do not show nuclear localization for either TEAD or YAP.
(legend continued on next page)
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et al., 2012; Org et al., 2015). Early transcription factor binding is
therefore required to express genes at the correct develop-
mental stage and at the appropriate level.
Recapitulation of Early Developmental Processes
during Reprogramming
The activation of a hematopoietic gene expression program in
unrelated cells by external factors requires the alteration of the
chromatin and transcriptional landscape and the activation of
hematopoietic genes. Our dynamic GRNmodel provided essen-
tial clues about which factors (TAL1 and LMO2) were the most
likely to succeed in this task and which ones would not. How-
ever, the actual molecular mechanism by which this occurs re-
quires further investigation. E-Box motifs are widespread in the
genome and are used by a variety of factors; we therefore sug-
gest that the interaction with the bridging molecule LMO2 (Wad-
man et al., 1997) is crucial in bringing in additional factors. LMO2
forms part of a complex consisting of various E-box binding pro-
teins as well as GATA, ETS, or RUNX1, and recruits LDB1 (My-
lona et al., 2013). The latter mediates interactions between
enhancer and promoter elements (Deng et al., 2012). The ETS
factor ETV2 (ER71) is expressed in hemangioblasts and has
been shown to be absolutely required for hematopoietic specifi-
cation (Liu et al., 2015). This factor, together with GATA2 and
TAL1, is capable of inducing enhanced hemangioblast formation
during ES cell differentiation (Liu et al., 2013). However, TAL1
expression could rescue the hematopoietic defect in ETV2/
cells, but FLI1 and GATA2 could not (Wareing et al., 2012), and
when included in preliminary reprogramming experiments,
ETV2 was incapable of generating hematopoietic colonies, on
its own or in combination with either LMO2 or TAL1 (data not
shown). These findings highlight the central role of the TAL1/
LMO2 complex in driving a blood-cell-specific gene expression
program and indicate that factors too far upstream in the
hematopoietic specification hierarchy cannot substitute for
hematopoietic factors.
TEAD Factors Regulate Hematopoietic Specification
in Mice
Our study provided an example of how our data resource can
be used to advance our understanding of hematopoietic spec-
ification, in this case by using the differential analysis of en-
riched motifs in DHS. This type of analysis confirmed the role
of known factors (such as RUNX1) but also identified a number
of potential cell-stage-specific regulators of hematopoietic
specification, leading to the identification of motifs for the
Hippo-regulated TEAD TFs enriched specifically in MES, HB,
and HE. Immunostaining analyses confirmed the presence of
YAP in the nucleus of cells at stages prior to the EHT in both
ESCs and embryo-derived cells, but not thereafter. Our func-
tional studies show that the interaction of TEAD factors and
the YAP co-factor in the nucleus at this early stage is strictly(B and C) TEAD activity is required during the early phase of hematopoietic com
added on day 1, 2, 3, or 4 of EB culture. Day-1 EB corresponds tomesoderm (MES
and HP specification. The frequency of CD41+ hematopoietic cells was determine
of CD41+ cells from nR 3 independent experiments. Data presented are mean
(D) Genome browser screenshot showing TEAD4 binding to the Tal1 locus in HB
(E) Genomic distribution of TEAD4 peaks together with TF binding motifs enriche
584 Developmental Cell 36, 572–587, March 7, 2016 ª2016 The Authrequired for the formation of hematopoietic precursor cells
from both sources.
How could TEAD factors impact on hematopoietic specifica-
tion in the embryo? The analysis of their target genes in this
study suggests that the TEAD/YAP complex may integrate the
response to different types of signaling via interaction with
genes encoding numerous signaling molecules whose balance
controls hematopoietic specification such as bone morphoge-
netic proteins, NODAL and WNT, and fibroblast growth factor
receptors (Pouget et al., 2014; Simoes et al., 2011). Moreover,
TEAD/YAP interacts with genes of the Rap1 pathway, which
controls cell adhesion dynamics and is essential for embryonic,
but not adult hematopoiesis (Satyanarayana et al., 2010).
Several recent studies have shown that the TEAD/YAP complex
cooperates with tissue-specific TFs to either activate or repress
gene expression. In human ESCs, TEAD/YAP interact with
OCT4 to maintain the expression of pluripotency genes and re-
presses mesendodermal genes, whereby repression can be
overcome by the activation of BMP and Wnt signaling (Beyer
et al., 2013; Estaras et al., 2015). The footprint of this interaction
in the epigenome can be seen in our data as a co-localization of
TEADmotifs with binding motifs for pluripotency factors in ESCs
(Figures 6B and S6A). Our data show that in developing hemato-
poietic cells TEAD peaks co-localize with TAL1/LMO2 com-
plexes, and SCL/TAL1 motif co-association continues to be
significant up to the HE stage, but, again, not thereafter. This
finding suggests that the factor complexes on such cis-regula-
tory elements may respond to Hippo signaling before, but not
after the EHT. We have previously shown that genes associated
with TAL1 and FLI1 binding in the HE are highly enriched for
genes regulating cell shape and focal adhesion. During the
EHT RUNX1 is strongly upregulated and relocates TAL1 and
FLI1 to new binding sites after the EHT (Lichtinger et al.,
2012), thus explaining the absence of co-localizing TEAD motifs
in HPs. The expression of all TEADs as well as YAP is downre-
gulated during terminal differentiation of HPs (Table S1A), thus
uncoupling cis-element activity from TEAD-mediated signaling
processes. Our analysis suggests the presence of a dynamic
GRN of tissue-specific and lineage-specifying TFs that is intri-
cately connected with signaling-responsive TFs such as TEAD
or TCF7L1/2. Our data resource will enable numerous further
functional and computational studies to examine the role of
these different factors and thus gain insights into the molecular
control mechanisms that underpin crucial steps in blood
specification.
EXPERIMENTAL PROCEDURES
A detailed description of all experiments can be found in Supplemental Exper-
imental Procedures. All animal work was performed under regulation in accor-
dancewith the United KingdomAnimal Scientific Procedures Act (ASPA) 1986.
Animal experiments were approved by the Animal Welfare and Ethics Review
Body (AWERB) of the Cancer Research UK Manchester Institute.mitment. The TEAD-YAP inhibitor verteporfin (9.6 mM) or DMSO vehicle was
) commitment, day 2–3 to hemangioblast (HB), commitment and day 4–5 to HE
d on day 7. (B) Representative FACS plots. (C) Quantification of the percentage
± SEM, paired t test.
together with other chromatin and binding features.
d in distal (left) and proximal (right) peaks.
ors
Isolation of Cell Populations
A mouse ES cell line carrying a brachyury (Bry) GFP+ reporter gene was
cultured as described by Sroczynska et al. (2009). GFP and cell surfacemarker
staining were used to identify each cell population by cell sorting. MES
cells were (Bry+Flk1), HB cells were (Bry+/Flk1+), HE cells were Tie2+/cKit+/
CD41), and HPs were CD41+. Macrophages were isolated by differentiation
of CD41+ cells to CD11b-expressing cells.
Chromatin Immunoprecipitation followed by Next-Generation
Sequencing
For each stage of differentiation cells were sorted, crosslinked, and stored
either as frozen cells (histone modification ChIP) or nuclei (TF ChIP) for subse-
quent ChIP assays, performed as described previously (Lichtinger et al., 2012;
Wilson et al., 2009). A full list of antibody sources is given in Supplemental
Experimental Procedures.
DNaseI and ChIP samples were amplified and sequenced according to the
manufacturer’s instructions. Some samples (MES, HB and HP H3K4me3,
HP H3K27me3, and HP H3K27ac) were processed using an ABI SOLiD 4
sequencer, and subsequently either the Illumina 2G Genome Analyzer or the
Hi-Seq 2000 were used.
RNA Sequencing
RNA preparation and sequencing were performed as described previously
(Lie-A-Ling et al., 2014).
DNaseI Sequencing
One to three million freshly sorted cells were digested with DNaseI enzyme
as described in detail previously (Ptasinska et al., 2014) and size selected
for 50- to 300-bp fragments.
Reprogramming Experiments
E14.5murinewild-type fibroblasts (MEFs) or from iTal1-2A-GFP transgenicmice
carrying rtTA and TRE-TAL1 cassettes allowing inducible expression of TAL1
upon addition of doxycycline were prepared as described previously (Sroczyn-
ska et al., 2009). Reprogramming experiments were carried out with either wild-
type (n = 5) or iTal1-2A-GFP (n = 2) MEFs as described by Batta et al. (2014).
Inhibition of TEAD/YAP Interaction In Vitro and Ex Vivo
Verteporfin was added to day-1, -2, -3, or -4 EB cultures at a final concentration
of 9.6 mM, and EB-derived cells were stained with CD41-PE and CD45-brilliant
violet 421 (Becton Dickinson) and analyzed by flow cytometry. BRY+/FLK1
mesoderm-enriched population was cultured for 48 hr with or without vertepor-
fin. Expression of Fgf5, Bry, and Flk1was measured by RT-PCR. FLK1+/CD41
HE-enriched cells were sorted from E7.5 embryos by fluorescence-activated
cell sorting (FACS) and cultured for 4 days on irradiated OP9 in HE media,
and hematopoietic differentiation of HE cells was measured by staining with a
CD41-PE antibody. CD45+ committed hematopoietic cells were sorted from
E10.5 embryos and cultured onOP9with verteporfin or DMSO.Growth and sur-
vival of hematopoietic cells was assessed by FACS after staining with a CD45-
fluorescein isothiocyanate antibody.
Immunostaining of Embryos
E7.5 embryos were fixed in 4% paraformaldehyde, mounted, and stained with
rabbit Pan-TEAD (D3F7L, New England Biolabs) (1:100), rabbit YAP (D8HIX
XP, New England Biolabs) (1:100), or purified anti-mouse Tie2 (Tek-CD202B,
14-5987-85, eBioscience) (1:100). Secondary antibodies were Alexa Fluor 488
goatanti-rat immunoglobulinG (IgG) (A11006, LifeTechnologies) andAlexaFluor
647 F(ab0)2 fragment of goat anti-rabbit IgG (H + L) (A21246, Life Technologies).
Data Analysis
A detailed description of all bioinformatics methods can be found in Supple-
mental Experimental Procedures.
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